D. Barnard

发表

Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B

Timothy B. Stockwell, T. Stockwell, K. Spurgers, 2019, Scientific Reports.

Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus.

D. Barnard, R. Sidwell, S. G. Wood, 1992, Antiviral research.

Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.

D. Barnard, Y. Kumaki, 2011, Future virology.

Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model

A. Salazar, D. Barnard, M. Wandersee, 2016, Antiviral Research.

Prophylactic and Therapeutic and Adjuvant Properties of Intranasal the Immunemodulator , Hiltonol ® ( Poly IC : LC ) , in a Lethal SARS-CoV-Infected BALB / C Mouse Model

A. Salazar, D. Barnard, M. Wandersee, 2016 .

Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells

D. Smee, D. Barnard, M. Wandersee, 2008, Biochemical and Biophysical Research Communications.

Antiviral Activity of Nucleoside Analogues against SARS-coronavirus (SARS-CoV)

S. Olgen, H. Choo, C. K. Chu, 2006, Antiviral chemistry & chemotherapy.

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV

D. Barnard, Gale Smith, M. Massare, 2011, Vaccine.

Respiratory syncytial virus infections: recent prospects for control.

D. Barnard, R. Sidwell, 2006, Antiviral research.

In Vitro Activity of Expanded-Spectrum Pyridazinyl Oxime Ethers Related to Pirodavir: Novel Capsid-Binding Inhibitors with Potent Antipicornavirus Activity

D. Smee, S. Tucker, D. Barnard, 2004, Antimicrobial Agents and Chemotherapy.

Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice.

D. Smee, Steven J M Jones, D. Barnard, 2016, Antiviral research.

Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice

D. Barnard, R. Sidwell, K. Bailey, 2006, Antiviral chemistry & chemotherapy.

Interaction of the human adenovirus proteinase with its 11-amino acid cofactor pVIc.

K. Thorn, M. Baniecki, P. Pellicena, 2001, Biochemistry.

Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice

D. Barnard, G. Lowell, T. Jones, 2007, Vaccine.

Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model

Jason R. Madsen, D. Barnard, M. Wandersee, 2010, Antiviral Research.

Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin

Jongdae Lee, H. Cottam, D. Carson, 2006, Antiviral Research.

Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model

O. Bohorov, N. Bohorova, M. Pauly, 2013, mAbs.

Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice.

D. Barnard, Y. Kumaki, J. Morrey, 2012, Future virology.

The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice

D. Smee, A. Sampath, D. Barnard, 2016, Viruses.

RWJ-270201 BioCryst Pharmaceuticals/Johnson & Johnson.

D. Barnard, 2000, Current opinion in investigational drugs.

Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine.

D. Smee, A. Van Aerschot, D. Barnard, 1992, Antiviral research.

Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice.

D. Barnard, A. Vollmer, M. Gebre, 2016, Antiviral research.

A broadly neutralizing human monoclonal antibody is effective against H7N9

Vidya Subramanian, H. Yen, G. Wogan, 2015, Proceedings of the National Academy of Sciences.

Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology

N. Petrovsky, D. Barnard, C. Tseng, 2014, Journal of Virology.

Neutralizing Viruses in Suspensions by Copper Oxide-Based Filters

Humberto H. Lara-Villegas, D. Smee, D. Barnard, 2007, Antimicrobial Agents and Chemotherapy.

Targeting ER α-glucosidase I with a single-dose iminosugar treatment protects against lethal influenza and dengue virus infections.

R. Dwek, P. Roversi, N. Zitzmann, 2020, Journal of medicinal chemistry.

Potent in vitro Activity of the Albumin Fusion Type 1 Interferons (Albumin-Interferon-Alpha and Albumin-Interferon-Beta) against RNA Viral Agents of Bioterrorism and the Severe Acute Respiratory Syndrome (SARS) Virus

P. Moore, D. Barnard, R. Sidwell, 2008, Chemotherapy.

Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice.

D. Smee, D. Barnard, E. B. Tarbet, 2013, Future virology.

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

D. Smee, D. Barnard, B. Gowen, 2009, Antiviral Research.

A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays.

D. Smee, D. Barnard, J. Roth, 2008, Antiviral research.

In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.

D. Smee, D. Barnard, Y. Kumaki, 2011, Antiviral research.

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant

N. Petrovsky, D. Barnard, M. Cox, 2015, Methods in molecular biology.

Technology evaluation: Sch-58500, Canji.

D. Barnard, 2000, Current opinion in molecular therapeutics.

Human Parainfluenza Virus Type 3 (HPIV‐3): Construction and Rescue of an Infectious, Recombinant Virus Expressing the Enhanced Green Fluorescent Protein (EGFP)

D. Barnard, J. Roth, J. K. Li, 2010, Current protocols in microbiology.

Efﬁcacy of Orally Administered T-705 on Lethal Avian Inﬂuenza A (H5N1) Virus Infections in Mice (cid:1)

D. Smee, D. Barnard, R. Sidwell, 2007 .

Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory Viruses

T. Douglas, M. Jutila, T. Randall, 2009, PloS one.

Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus

Y. Chao, J. Jan, Shiow-Ju Lee, 2010, Antiviral Research.

Examining the interactions of Galahad™ compound with viruses to develop a novel inactivated influenza A virus vaccine

P. Azadi, D. Belnap, D. Barnard, 2022, Heliyon.

An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.

S. Tucker, D. Barnard, R. Sidwell, 2003, Journal of medicinal chemistry.

Favipiravir (T-705), a novel viral RNA polymerase inhibitor.

D. Smee, D. Barnard, B. Gowen, 2013, Antiviral research.

Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus.

D. Smee, D. Barnard, J. Morrey, 2011, Antiviral research.

Coumarins and Pyranocoumarins, Potential Novel Pharmacophores for Inhibition of Measles Virus Replication

D. Smee, D. Barnard, R. Sidwell, 2002, Antiviral chemistry & chemotherapy.

(-)-Carbodine: enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu).

D. Smee, C. K. Chu, D. Barnard, 2010, Bioorganic & medicinal chemistry letters.

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

R. Baric, D. Smee, M. Frieman, 2009, Virology.

Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.

D. Smee, D. Barnard, R. Sidwell, 2002, Journal of virological methods.

Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities

D. Smee, D. Barnard, R. Sidwell, 2001, Antimicrobial Agents and Chemotherapy.

Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine.

D. Barnard, R. Sidwell, J. Huffman, 1993, Antiviral research.

Novel 3-sulphonamido-quinazolin-4(3H)-One Derivatives: Microwave-Assisted Synthesis and Evaluation of Antiviral Activities against Respiratory and Biodefense Viruses

D. Smee, D. Barnard, P. Selvam, 2007, Antiviral chemistry & chemotherapy.

Current status of anti-picornavirus therapies.

D. Barnard, Dale L Barnard, 2006, Current pharmaceutical design.

in vitro inhibition of the measles virus by novel ring-expanded ('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring system.

D. Barnard, A. Fattom, R. Sidwell, 2002, Bioorganic & medicinal chemistry letters.

Protease inhibitors targeting coronavirus and filovirus entry

Yanchen Zhou, Dale Barnard, Adam R. Renslo, 2015, Antiviral Research.

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

D. Meyerholz, J. Mcmahon, C. Wohlford-Lenane, 2009, Journal of Virology.

Design, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives.

M. K. Kim, Y. Chong, D. Barnard, 2013, Chemical & pharmaceutical bulletin.

Interferon Alfacon-1 Protects Hamsters from Lethal Pichinde Virus Infection

D. Smee, D. Barnard, R. Sidwell, 2005, Antimicrobial Agents and Chemotherapy.

Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice

D. Smee, D. Barnard, R. Sidwell, 2006, Antimicrobial Agents and Chemotherapy.

Inhibitors of Measles Virus

D. Barnard, 2004, Antiviral chemistry & chemotherapy.

Review Inhibitors of measles virus

D. Barnard, 2004 .

Inhibition of adenovirus serotype 14 infection by octadecyloxyethyl esters of (S)‐[(3‐hydroxy‐2‐phosphonomethoxy)propyl]‐ nucleosides in vitro

D. Smee, D. Barnard, K. Hostetler, 2018, Antiviral research.

Inhibition of Measles Virus Replication by 5′-Nor Carbocyclic Adenosine Analogues

D. Barnard, Subha R. Das, Valerie D Stowell, 2001, Antiviral chemistry & chemotherapy.

Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and β-D-N4-Hydroxycytidine

M. Otto, D. Smee, D. Barnard, 2004, Antiviral chemistry & chemotherapy.

Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin

D. Smee, G. Simmons, D. Barnard, 2010, Antiviral Research.

Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication in a Lethal SARS-Cov Balb/C Mouse Model by Stinging Nettle Lectin, Urtica Dioica Agglutinin (UDA)

D. Smee, D. Barnard, M. Wandersee, 2010, Antiviral Research.

Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives.

D. Barnard, R. Sidwell, K. O’Neill, 1995, Antiviral research.

Selective inhibition ofcytomegaloviruses by 9-(3'-ethyl phosphonyl-1'-hydroxymethyl-1'-propyloxy-methyl)guanine

D. Barnard, R. Sidwell, J. Huffman, 1993 .

Effect of phosphonic acidanalogs of acyclovir and ganciclovir on in vitro cytomegalovirus infections

D. Barnard, R. Sidwell, J. Huffman, 1989 .

Antiviral Activities and Phosphorylation of 5-halo-2'-Deoxyuridines and N-Methanocarbathymidine in Cells Infected with Vaccinia Virus

D. Smee, D. Barnard, B. Hurst, 2008, Antiviral chemistry & chemotherapy.

In vitro and in vivo influenza virus-inhibitory effects of viramidine.

D L Barnard, D. Smee, D. Barnard, 2005, Antiviral research.

Outbreak in Bristol of Conjunctivitis Caused by Adenovirus Type 8, and its Epidemiology and Control

D. Barnard, J. Hart, V. Marmion, 1973, British medical journal.

In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus

D. Smee, D. Barnard, A. Vollmer, 2014, Archives of Virology.

Topographical analysis of the G virion of Aleutian mink disease parvovirus with monoclonal antibodies

D. Barnard, F. Johnson, 2005, Archives of Virology.

Fatal marrow aplasia associated with non-A, non-B hepatitis.

D. Barnard, M. Losowsky, P. Bannister, 1983 .

Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza

Dean Y. Li, M. Krasnow, G. Zimmerman, 2010, Science Translational Medicine.

Suitability of new chlamydia transport medium for transport of herpes simplex virus

F. B. Johnson, D. Barnard, K. Farnes, 1986, Journal of clinical microbiology.

Comparison of an avidin-biotin immunoassay with three commercially available immunofluorescence kits for typing of herpes simplex virus.

F. B. Johnson, D. Barnard, D. Richards, 1985, Journal of clinical pathology.

Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B

T. Stockwell, K. Spurgers, Lisa Evans DeWald, 2019, Scientific Reports.

New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion

D. Moir, A. Basu, Lijun Rong, 2013, Journal of Virology.

Animal models for the study of influenza pathogenesis and therapy

D. Barnard, Dale L. Barnard, 2009, Antiviral Research.

Antiviral Agents Derived from Novel 1-adamantyl Singlet Nitrenes

R. Schinazi, D. Barnard, A. Schönleber, 2012, Antiviral chemistry & chemotherapy.

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

D. Meyerholz, J. Mcmahon, C. Wohlford-Lenane, 2010, Journal of Virology.

Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections?

D. Barnard, R. Sidwell, K. Bailey, 2008, Antiviral Research.

Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses

D. Smee, D. Barnard, M. D. de Jong, 2012, PloS one.

Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.

A. Basu, Lijun Rong, M. Caffrey, 2017, ACS infectious diseases.

Adenovirus Proteinase-Antiviral Target for Triple-Combination Therapy on a Single Enzyme: Potential Inhibitor-Binding Sites

R. Sweet, J. Ding, W. Mcgrath, 2000 .

Developments in the Search for Small-Molecule Inhibitors for Treatment of Severe Acute Respiratory Syndrome Coronavirus

D. Barnard, Y. Kumaki, 2009 .

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.

D. Barnard, R. Sidwell, K. Bailey, 1998, Antiviral research.

Methods for evaluation of antiviral efficacy against influenza virus infections in animal models.

D. Smee, D. Barnard, 2013, Methods in molecular biology.

In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201

D. Smee, D. Barnard, R. Sidwell, 2001, Antimicrobial Agents and Chemotherapy.

Effect of Oral Gavage Treatment with ZnAL42 and other Metallo-Ion Formulations on Influenza a H5N1 and H1N1 Virus Infections in Mice

D. Barnard, R. Sidwell, K. Bailey, 2007, Antiviral chemistry & chemotherapy.

Utilization of Alpha-1-Acid Glycoprotein Levels in the Serum as a Parameter for in Vivo Assay of Influenza Virus Inhibitors

D. Smee, D. Barnard, R. Sidwell, 2001, Antiviral chemistry & chemotherapy.

Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.

D. Smee, K. Bush, D. Barnard, 2001, Antiviral research.

Induction of Interferon-γ-Inducible Protein 10 by SARS-CoV Infection, Interferon Alfacon 1 and Interferon Inducer in Human Bronchial Epithelial Calu-3 Cells and BALB/c Mice

Jason R. Madsen, D. Smee, A. Salazar, 2010, Antiviral chemistry & chemotherapy.

Progression of Aleutian disease in natural and experimentally induced infections of mink.

D. Barnard, J. Morrey, L. C. Ellis, 1996, American journal of veterinary research.

SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago).

A Brazier, D. Smee, K. Nakanishi, 1994, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Evaluation of Interferon Inducers, Ribavirin and Mouse Hyperimmune Serum in a Pathogenesis/Lethal Mouse Model Using a Mouse-adapted SARS-CoV

A. Salazar, D. Barnard, M. Wandersee, 2008, Antiviral Research.

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

D. Smee, D. Barnard, B. Gowen, 2009, Antiviral Research.

Interferon alfacon 1 inhibits SARS-CoV infection In human bronchial epithelial Calu-3 cells

D. Smee, D. Barnard, M. Wandersee, 2017 .